|
Leica Biosystems (founded 1989) is a biotechnology company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company and a division of Danaher Corporation. ==Company Description== The company has headquarters in Germany with operations in the United Kingdom, Australia, China, Singapore, Illinois, and Boston. A temporary research and development facility concentrating on cancer diagnostics has been in operation in Danvers, Massachusetts since August 2012.〔Seiffert, Don. (“Leica Biosystems plans to expand R&D facility in Mass.” ) Boston Business Journal. Feb. 1, 2013〕 The Massachusetts facility partners with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine.〔Weintraub, Karen. (“Leica Biosystems plans R&D expansion in area.” ) The Boston Globe. Feb. 25, 2013〕 Leica Biosystems acquired Aperio, an ePathology solutions company, in October 2012.〔(“Leica Biosystems completes acquisition of Aperio.” ) Yahoo Finance. Oct. 24, 2012〕 In October 2014, the company announced they were purchasing Devicor Medical Products, which is headquartered in Cincinnati and makes medical devices used in breast biopsies.〔Collins, Allison. (“Leica Biosystems Adds GTCR-Backed Devicor Medical Products.” ) Mergers and Acquisitions. Oct. 28, 2014〕 The company partners with Mayo Clinic’s Department of Laboratory Medicine and Pathology in developing cytogenetics imaging software.〔(“Leica Biosystems and Mayo Clinic Collaborate on Future of Cytogenetics Imaging.” ) Mayo Clinic Blog. December 15, 2014〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Leica Biosystems」の詳細全文を読む スポンサード リンク
|